Recent Highlights and Expert Opinion on Psoriasis Management
Journal Title: Journal of Dermatology Research - Year 2020, Vol 1, Issue 1
Abstract
Psoriasis is a common chronic inflammatory skin disorder characterized by red, flaky, crusty, scaly, itchy, thickened plaques (Fig. 1), which affects approximately 2% of the population worldwide [1-2]. Increasing evidences supports the recognition of psoriasis as a multisystem chronic inflammatory disorder with multiple associated comorbidities, including myocardial infarction, metabolic syndrome, diabetes (Type 2 diabetes) and/or Crohn’s disease [3-6].
Authors and Affiliations
Farid Menaa
The Weight of Traditional Therapy in The Management of Chronic Skin Diseases in Donka National Hospital
Chronic skin diseases affect patients’ physical, psychological and social well-being. They lead patients to seek care in conventional and traditional medicine. The aim of this study was to determine the contributions of...
Immunophenotypes in Atopic Dermatitis
Atopic Dermatitis is a very heterogeneous and complex disease. Recently, the ethnic background has been reported as a determining factor for a better understanding of genetic differences, clinical phenotypes, and immun...
JAK Inhibitor Baricitinib in the Treatment of Oral Lichen Planus: A Case Report
Baricitinib, a JAK1/2 inhibitor, has been expanding its role as a therapeutic agent with recent FDA approval for dermatologic use with alopecia areata. Clinical trials are underway for further use of baricitinib for seve...
Cutaneous Loxoscelism On 5 Moroccan Cases
Introduction: Loxoscelism is an under-diagnosed condition due to lack of awareness among practitioners. It is a serious form of araneism that can be strictly cutaneous with variable clinical aspects that can be deadly....
Nail Involvement in Pemphigus: Brief Report
Background: The objective of our study is to describe the different nail involvement at the beginning of the disease according to the type of pemphigus and according to the severity of the pemphigus. Material and meth...